Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Danish drug maker Santaris considers U.S. listing -investor
Yahoo/Reuters
Wednesday, March 26, 2014 - 12:26pm
tags:
Santaris
GSK reports tampering of some bottles of weight-loss drug
Yahoo/Reuters
Wednesday, March 26, 2014 - 11:42am
tags:
GSK, tampering, Alli
Depomed A 'Turtle' Gaining In Specialty Pharma Race
Investors.com
Wednesday, March 26, 2014 - 11:39am
tags:
Depomed, Cambia, Gralise, Xartemis XR, JNJ, Mallinckrodt, Nucynta
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wednesday, March 26, 2014 - 8:30am
tags:
AbbVie, Amgen, Gilead Sciences, Achillion, Alexion, Ariad Pharmaceuticals, Pharmacyclics, Seattle Genetics
Wanna team with AstraZeneca? Post on its website
Fierce Biotech
Wednesday, March 26, 2014 - 8:12am
tags:
innovation, R&D, AstraZeneca
NeuroPhage adds a $17M round to back Alzheimer's drug program
Fierce Biotech
Wednesday, March 26, 2014 - 8:11am
tags:
NeuroPhage, Alzheimer's disease, NPT088
Pharma and the First Amendment: A Proposal From the FDA
WSJ Online
Wednesday, March 26, 2014 - 8:09am
tags:
First Amendment, FDA, off-label
Gene Therapy's Big Comeback
Forbes
Wednesday, March 26, 2014 - 8:07am
tags:
gene therapy, Bristol-Myers Squibb, Bluebird Bio, NightstaRx, Voyager Therapeutics, uniQure, Celladon, Juno Therapeutics, Editas Medicine, Gensight Biologics, Audentes Therapeutics, Dimension Therapeutics
Time to Focus on Alexion (ALXN) for Strong Earnings Growth Potential
Yahoo/Zacks.com
Wednesday, March 26, 2014 - 8:04am
tags:
earnings, Alexion
Insmed's lung infection drug fails mid-stage study
Yahoo/Reuters
Wednesday, March 26, 2014 - 8:03am
tags:
Insmed, Arikace, nontuberculous mycobacterial lung infections
GSK melanoma drug combination faces delay in Europe
Yahoo/Reuters
Wednesday, March 26, 2014 - 8:01am
tags:
GSK, Europe, melanoma, Mekinist, Tafinlar
3 Biotechs Expecting Top Line Phase 2 Data Mid 2014
Seeking Alpha
Wednesday, March 26, 2014 - 7:59am
tags:
Biota Pharmaceuticals, Laninamivir Octanoate, Flu, Inovio, VGX-3100, DNA vaccines, MultiStem, Athersys, Pfizer, ulcerative colitis
Biogen cozies up to MIT with a $5.3M drug discovery pact
Fierce Biotech
Tuesday, March 25, 2014 - 9:44pm
tags:
Biogen Idec, MIT, drug discovery
Sanofi's Getting Back in the Game
Yahoo/Guru Focus
Tuesday, March 25, 2014 - 8:03pm
tags:
Sanofi, patents, Lemtrada
Gilead Following Multiple Paths Toward HIV “Functional Cure”
Motley Fool
Tuesday, March 25, 2014 - 8:01pm
tags:
Gilead Sciences, HIV
Dendreon Ready For A Rebound
Seeking Alpha
Tuesday, March 25, 2014 - 7:59pm
tags:
Dendreon
FDA: More Than 3.4 Million Hours Spent Each Year Filing New and Generic Drug Applications
Regulatory Focus
Tuesday, March 25, 2014 - 10:25am
tags:
FDA
Pfizer lung cancer drug beats chemo for previously untreated patients
Yahoo/Reuters
Tuesday, March 25, 2014 - 10:00am
tags:
Pfizer, Xalkori, lung cancer
The 10 best-selling drugs of 2013
Fierce Pharma
Tuesday, March 25, 2014 - 9:56am
tags:
Seretide, Rituxan, Remicade, MabThera, Lantus, Humira, Herceptin, Enbrel, Crestor, Avastin, Advair, Abilify
AbbVie CEO's pay doubles to $18.2M in Abbott pharma spinoff's first solo year
Fierce Pharma
Tuesday, March 25, 2014 - 9:54am
tags:
AbbVie, Pharma CEOs, executive pay, Richard Gonzalez

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.